Compare LACTOSE INDIA with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA NEULAND LABS LACTOSE INDIA/
NEULAND LABS
 
P/E (TTM) x -84.6 30.7 - View Chart
P/BV x 1.3 2.9 45.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 LACTOSE INDIA   NEULAND LABS
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
NEULAND LABS
Mar-21
LACTOSE INDIA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs422,350 1.8%   
Low Rs16260 6.1%   
Sales per share (Unadj.) Rs30.6730.3 4.2%  
Earnings per share (Unadj.) Rs-2.262.8 -3.4%  
Cash flow per share (Unadj.) Rs1.693.8 1.8%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs30.1613.0 4.9%  
Shares outstanding (eoy) m11.4412.83 89.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.91.8 52.8%   
Avg P/E ratio x-13.320.8 -64.2%  
P/CF ratio (eoy) x17.613.9 126.2%  
Price / Book Value ratio x1.02.1 45.0%  
Dividend payout %08.0 0.0%   
Avg Mkt Cap Rs m33016,746 2.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1061,497 7.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3509,369 3.7%  
Other income Rs m3161 1.9%   
Total revenues Rs m3539,530 3.7%   
Gross profit Rs m621,468 4.2%  
Depreciation Rs m44397 11.0%   
Interest Rs m54179 30.4%   
Profit before tax Rs m-331,053 -3.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-8247 -3.2%   
Profit after tax Rs m-25806 -3.1%  
Gross profit margin %17.815.7 113.6%  
Effective tax rate %24.223.5 103.4%   
Net profit margin %-7.18.6 -82.3%  
BALANCE SHEET DATA
Current assets Rs m1975,496 3.6%   
Current liabilities Rs m1163,685 3.2%   
Net working cap to sales %23.119.3 119.5%  
Current ratio x1.71.5 113.6%  
Inventory Days Days5926 224.7%  
Debtors Days Days67185 791.2%  
Net fixed assets Rs m6867,752 8.9%   
Share capital Rs m114129 88.7%   
"Free" reserves Rs m2307,736 3.0%   
Net worth Rs m3457,865 4.4%   
Long term debt Rs m393881 44.6%   
Total assets Rs m88313,248 6.7%  
Interest coverage x0.46.9 5.8%   
Debt to equity ratio x1.10.1 1,016.0%  
Sales to assets ratio x0.40.7 56.0%   
Return on assets %3.47.4 45.2%  
Return on equity %-7.210.3 -70.1%  
Return on capital %3.014.1 21.0%  
Exports to sales %077.8 0.0%   
Imports to sales %7.429.5 25.1%   
Exports (fob) Rs mNA7,292 0.0%   
Imports (cif) Rs m262,765 0.9%   
Fx inflow Rs m257,292 0.3%   
Fx outflow Rs m272,765 1.0%   
Net fx Rs m-24,527 -0.0%   
CASH FLOW
From Operations Rs m221,894 1.1%  
From Investments Rs m-62-844 7.3%  
From Financial Activity Rs m45-1,137 -4.0%  
Net Cashflow Rs m5-88 -5.8%  

Share Holding

Indian Promoters % 49.1 36.2 135.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 21.7 3.1%  
FIIs % 0.0 16.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 63.8 79.8%  
Shareholders   15,737 34,332 45.8%  
Pledged promoter(s) holding % 47.2 4.3 1,096.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   NUTRAPLUS PR  LUPIN  FREDUN PHARMA  RELISH PHARMA  LINK PHARMA  



Today's Market

Sensex Falls 1,100 Points from Day's High to End Marginally Lower; Metal & Energy Stocks Witness Selling(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices reversed course in intraday deals as global cues turned bearish.

Related Views on News

NEULAND LABS 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of NEULAND LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Nov 30, 2021 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - BAL PHARMA COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS